GGrantIndex
Sort

166,118 grants matching stem cells

SV40-BASED COMBINATION GENETIC THERAPIES FOR HIV/SIV

$824,882
Thomas Jefferson University · P01 · FY2000 · AI

Nervous System Development and Plasticity

$824,847
Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD

Tracking the origin of tau pathology

$824,816
Heidi Irma Jacobs · Massachusetts General Hospital · R01 · FY2022 · AG

Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease

$824,767
Yu-Shin Ding · New York University School Of Medicine · R01 · FY2023 · AG

Acquisition Of A High-End, High-Speed Cell Sorter With Bio-Containment Hood

$824,680
Timothy P Bushnell · University Of Rochester · S10 · FY2010 · RR

2/7-Collaborative genomic studies of Tourette Disorder

$824,661
Matthew W State · University Of California, San Francisco · R01 · FY2019 · MH

Genetic and molecular basis for SRSF2 mutations in myelodysplasia

$824,642
Robert K Bradley · Fred Hutchinson Cancer Research Center · R01 · FY2020 · HL

Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infection

$824,595
Adam Williams · Jackson Laboratory · U19 · FY2025 · AI

Calmodulin-driven Nuclear Trafficking linked to diabetes and insulin signaling

$824,564
John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Administrative Core COBRE Phase II Stem Cells and Aging

$824,535
Peter J Quesenberry · Rhode Island Hospital · P20 · FY2021 · GM

In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies

$824,437
Clotilde Lagier-Tourenne · Massachusetts General Hospital · R01 · FY2024 · NS

In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies

$824,437
Clotilde Lagier-Tourenne · Massachusetts General Hospital · R01 · FY2025 · NS

Engineering 2nd generation 5MCARs to monitor and treat Type-I Diabetes

$824,415
Michael S Kuhns · University Of Arizona · R01 · FY2025 · DK

Development of novel genomic approaches for profiling cellular temporal-spatial dynamics of neurogenesis in Aging and Alzheimer's disease

$824,323
Junyue Cao · Rockefeller University · R01 · FY2023 · AG

Illegitimate recombination by drug resistance elements

$824,299
Nancy E. Kleckner · Harvard University · R01 · FY2008 · GM

MCW NCTN Lead Academic Participating Site

$824,283
Stuart J Wong · Medical College Of Wisconsin · UG1 · FY2021 · CA

Brain Tumor Animal Therapeutics Core

$824,211
Howard Fine · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA

STUDIES OF NATURAL SIV INFECTION OF SOOTY MANGABEYS

$824,192
Guido Silvestri · Emory University · R37 · FY2020 · AI

Illegitimate recombination by drug resistance elements

$824,191
Nancy E. Kleckner · Harvard University · R01 · FY2007 · GM

Toward a Central Question in Epigenetics: A Major Epigenetic Programming Mechanis

$824,175
Haifan Lin · Yale University · DP1 · FY2014 · CA

Microengineered Osteons for Bone Tissue Engineering

$824,171
Yunzhi Yang · Stanford University · R01 · FY2016 · AR

Host DNA repair pathways in human cytomegalovirus replication

$824,149
Felicia D Goodrum · Dartmouth College · R01 · FY2025 · AI

Combination gene editing protocol using CRISPR technology for HIV/AIDS cure in non-human primates

$824,124
Tricia Helen Burdo · Temple Univ Of The Commonwealth · R56 · FY2020 · AI

Illegitimate recombination by drug resistance elements

$824,084
Nancy E. Kleckner · Harvard University · R01 · FY2006 · GM

Perfusable 3D human cardiac constructs for heart regeneration

$824,083
Ying Zheng · University Of Washington · R01 · FY2021 · HL